AZEDRA

Peak

iobenguane i-131

Progenicyte Therapeutics
NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Jul 2018
Lifecycle
Peak
Competitive Pressure
30/100
Company
Progenicyte Therapeutics
Progenicyte Therapeutics
IL - Chicago
External Resources
FDA Drugs@FDA
FDA approval history